ITNT

Clinical trials for ITNT explained in plain language.

Never miss a new study

Get alerted when new ITNT trials appear

Sign up with your email to follow new studies for ITNT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Triple threat: radiotherapy, chemo, and immunotherapy take on spread rectal cancer

Disease control Recruiting now

This phase 2 trial is testing a new approach for people with a specific type of rectal cancer that has spread to a few other spots in the body (oligometastases). The treatment combines short-course radiotherapy, chemotherapy (CAPEOX), and an immunotherapy drug called serplulimab …

Matched conditions: ITNT

Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

ITNT

Get alerted when new ITNT trials appear

Triple threat: radiotherapy, chemo, and immunotherapy take on spread rectal cancer